Physician

Alexander Joseph Pronko

According to 2025 Medicare claims, Alexander Pronko (NPI: 1760923072) practices pulmonary disease in the Newark, NJ market, with the plurality of this provider's patient population coming from Morris, NJ. This provider's primary affiliated billing organization is PRACTICE ASSOCIATES MEDICAL GROUP (NPI: 1427016385; TIN: 202088165) and primary practice location at 07960-6136. Pronko is affiliated with the Atlantic ACO (ACO ID: A1026), participating under the MSSP model.

Pronko's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 622 traditional Medicare patients, billed 1,534 HCPCS/CPT codes, and received $152,023 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 795 prescription claims across 230 beneficiaries totaling $243,616 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 198 claims. Open Payments data shows 5 records totaling $86. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $1,255 to $243,616. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	169	307	$33,107
2024	622	1,534	$152,023

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	12	$1,255
2018	17	82	$7,949
2019	46	165	$12,043
2020	18	58	$3,598
2021	N/R	64	$6,235
2022	17	71	$11,446
2023	51	143	$29,121
2024	230	795	$243,616

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	29	$1,633
2024	36	198	$5,681

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99291	Critical care, first 30-74 minutes	185	281	$175
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	133	173	$108
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	172	250	$100
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	126	163	$66
94726	Test to determine lung volumes using sensors	91	97	$24

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	90	3,300	$69,765
Breo Ellipta	Fluticasone/Vilanterol	113	3,870	$50,231
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	52	1,800	$36,476
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	29	1,410	$20,428
Incruse Ellipta	Umeclidinium Bromide	29	870	$10,607

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	12	27	$2,019
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	26	$1,731
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	12	26	$638
E1392	Portable oxygen concentrator, rental	Y	N/R	16	$537
E0570	Nebulizer, with compressor	Y	12	74	$450

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$86	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alexander Joseph Pronko?

Tedicare shows public-source Medicare data for Alexander Joseph Pronko (NPI 1760923072), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexander Joseph Pronko have ACO affiliation data?

Alexander Joseph Pronko is shown with ACO affiliation data for Atlantic ACO (MSSP, ACO ID A1026).

What billing organization is linked to Alexander Joseph Pronko?

Alexander Joseph Pronko is linked to PRACTICE ASSOCIATES MEDICAL GROUP (billing NPI 1427016385) in the available physician profile data.

Does Alexander Joseph Pronko have Open Payments data?

Alexander Joseph Pronko has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.